inno-105
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2005 (NCT00255333)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Fibroblast growth factor receptor 4INHIBITOR
FGFR4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- inno-105
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00255333 | Phase 1 | Nov 1, 2005 | Innovive Pharmaceuticals, Mary Crowley Cancer Center, University of Maryland |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Innovive Pharmaceuticals | For profit | 1 | 1 | 1 | 2005 |
| Mary Crowley Cancer Center | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2005 |
3 organizations
Page 1 / 1